Looking Forward to the Future of Heparin: New Sources, Developments and Applications
This book is a printed edition of the Special Issue Looking Forward to the Future of Heparin: New Sources, Developments and Applications that was published in Molecules
Saved in:
: | |
---|---|
Year of Publication: | 2018 |
Language: | English |
Physical Description: | 1 electronic resource (282 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993544005904498 |
---|---|
ctrlnum |
(CKB)4920000000095222 (oapen)https://directory.doabooks.org/handle/20.500.12854/51985 (EXLCZ)994920000000095222 |
collection |
bib_alma |
record_format |
marc |
spelling |
Fareed, Jawed auth Looking Forward to the Future of Heparin: New Sources, Developments and Applications Looking Forward to the Future of Heparin MDPI - Multidisciplinary Digital Publishing Institute 2018 1 electronic resource (282 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier This book is a printed edition of the Special Issue Looking Forward to the Future of Heparin: New Sources, Developments and Applications that was published in Molecules English alginate edema Heparin Red solid lipid nanoparticles Fe3O4·DA-BSA/HA dermatan sulfate sulfated alginate porcine heparin theranostics low-molecular-weight heparin Arixtra® biomaterials hepcidin ovarian cancer iron oxide nanoparticles heparin-induced thrombocytopenia bone morphogenetic protein (BMP) hyaluronic acid (HA) crude heparin platelets resistance sclerostin LMWH gremlin low molecular weight heparin (LMWH) low molecular weight glycosaminoglycans human plasma single crystal X-ray structure iron homeostasis noggin super paramagnetic iron oxide nanoparticles (SPION) manufacturing methods paclitaxel (PTX) brain injury bovine heparin inflammation qNMR antithrombin reference standard quantitative NMR enoxaparin danaparoid sodium NMR GDNF orthogonal multi-analytical methods ternary complex heparan sulphate serglycin bovine serum albumin (BSA) HSQC recombinant expression heparin heparin oligosaccharides functional assay BMP antagonists intestinal lymphatic absorption size exclusion chromatography heparin coating diagnosis bioreactor anemia proteoglycan heparin process PCA chemometric fluorescent probe pharmacopeia affinity chromatography component quantitative analysis Fondaparinux sodium perylene diimide dyes thrombin inhibition extended physicochemical characterization cisplatin glycosaminoglycans TGF-? chondroitin sulfate dalteparin sequence and compositional investigations molecular weight magnetic resonance imaging (MRI) industrial LC-MS iduronic acid conformation heparan sulfate growth and differentiation factor (GDF) assay subarachnoid hemorrhage 3-03842-949-X Torri, Giangiacomo auth |
language |
English |
format |
eBook |
author |
Fareed, Jawed |
spellingShingle |
Fareed, Jawed Looking Forward to the Future of Heparin: New Sources, Developments and Applications |
author_facet |
Fareed, Jawed Torri, Giangiacomo |
author_variant |
j f jf |
author2 |
Torri, Giangiacomo |
author2_variant |
g t gt |
author_sort |
Fareed, Jawed |
title |
Looking Forward to the Future of Heparin: New Sources, Developments and Applications |
title_full |
Looking Forward to the Future of Heparin: New Sources, Developments and Applications |
title_fullStr |
Looking Forward to the Future of Heparin: New Sources, Developments and Applications |
title_full_unstemmed |
Looking Forward to the Future of Heparin: New Sources, Developments and Applications |
title_auth |
Looking Forward to the Future of Heparin: New Sources, Developments and Applications |
title_alt |
Looking Forward to the Future of Heparin |
title_new |
Looking Forward to the Future of Heparin: New Sources, Developments and Applications |
title_sort |
looking forward to the future of heparin: new sources, developments and applications |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2018 |
physical |
1 electronic resource (282 p.) |
isbn |
3-03842-950-3 3-03842-949-X |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT fareedjawed lookingforwardtothefutureofheparinnewsourcesdevelopmentsandapplications AT torrigiangiacomo lookingforwardtothefutureofheparinnewsourcesdevelopmentsandapplications AT fareedjawed lookingforwardtothefutureofheparin AT torrigiangiacomo lookingforwardtothefutureofheparin |
status_str |
n |
ids_txt_mv |
(CKB)4920000000095222 (oapen)https://directory.doabooks.org/handle/20.500.12854/51985 (EXLCZ)994920000000095222 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Looking Forward to the Future of Heparin: New Sources, Developments and Applications |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1792839734293168128 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04094nam-a2201345z--4500</leader><controlfield tag="001">993544005904498</controlfield><controlfield tag="005">20231214132955.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2018 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03842-950-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000000095222</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/51985</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000000095222</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Fareed, Jawed</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Looking Forward to the Future of Heparin: New Sources, Developments and Applications</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Looking Forward to the Future of Heparin</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (282 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book is a printed edition of the Special Issue Looking Forward to the Future of Heparin: New Sources, Developments and Applications that was published in Molecules</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">alginate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">edema</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Heparin Red</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">solid lipid nanoparticles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Fe3O4·DA-BSA/HA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dermatan sulfate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sulfated alginate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">porcine heparin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">theranostics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">low-molecular-weight heparin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Arixtra®</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomaterials</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepcidin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ovarian cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">iron oxide nanoparticles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heparin-induced thrombocytopenia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bone morphogenetic protein (BMP)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hyaluronic acid (HA)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">crude heparin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">platelets</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sclerostin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LMWH</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gremlin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">low molecular weight heparin (LMWH)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">low molecular weight glycosaminoglycans</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">human plasma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">single crystal X-ray structure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">iron homeostasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">noggin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">super paramagnetic iron oxide nanoparticles (SPION)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">manufacturing methods</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">paclitaxel (PTX)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">brain injury</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bovine heparin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">qNMR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antithrombin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">reference standard</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">quantitative NMR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">enoxaparin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">danaparoid sodium</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NMR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">GDNF</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">orthogonal multi-analytical methods</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ternary complex</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heparan sulphate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">serglycin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bovine serum albumin (BSA)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HSQC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">recombinant expression</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heparin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heparin oligosaccharides</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">functional assay</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BMP antagonists</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">intestinal lymphatic absorption</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">size exclusion chromatography</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heparin coating</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diagnosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bioreactor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anemia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">proteoglycan</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heparin process</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PCA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemometric</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fluorescent probe</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pharmacopeia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">affinity chromatography</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">component quantitative analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Fondaparinux sodium</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">perylene diimide dyes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">thrombin inhibition</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">extended physicochemical characterization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cisplatin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glycosaminoglycans</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TGF-?</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chondroitin sulfate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dalteparin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sequence and compositional investigations</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular weight</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">magnetic resonance imaging (MRI)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">industrial</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LC-MS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">iduronic acid conformation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heparan sulfate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">growth and differentiation factor (GDF)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">assay</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">subarachnoid hemorrhage</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03842-949-X</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Torri, Giangiacomo</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-03-07 03:45:29 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-11-10 04:18:40 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337474310004498&Force_direct=true</subfield><subfield code="Z">5337474310004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337474310004498</subfield></datafield></record></collection> |